Despite a previous conception that KRAS and BRAF mutations are mutually exclusive, we found 1 dual BRAFV600E+KRASA164V^submutated tumor that, in our case, was associated with poor prognostic features [19]. This evidence concerns the gene KRAS and neoplasm.